DNA Sequencing Trial Wraps, Illumina Rival Seeks Invalidity
Four subsidiaries of Chinese company BGI Group seeking to invalidate patents behind an American company's system for rapid DNA sequencing maintained in closing arguments at trial on Friday that the techniques...To view the full article, register now.
Already a subscriber? Click here to view full article